CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP 13D and 13G filings for Pluristem Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-06-01 07:36 am Sale | 2021-05-28 | 13G | Pluristem Therapeutics Inc. PSTI | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | 3,121,918 9.800% | -955,671 (-23.44%) | Filing |
| 2021-02-05 08:30 am Purchase | 2020-12-31 | 13G | Pluristem Therapeutics Inc. PSTI | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | 4,077,589 15.900% | 229,006 (+5.95%) | Filing |
| 2020-10-05 4:13 pm Purchase | 2020-09-29 | 13G | Pluristem Therapeutics Inc. PSTI | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | 3,848,583 15.100% | 1,337,272 (+53.25%) | Filing |
| 2020-06-29 7:22 pm Purchase | 2020-05-27 | 13G | Pluristem Therapeutics Inc. PSTI | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | 2,511,311 10.080% | 1,419,254 (+129.96%) | Filing |
| 2020-04-29 08:58 am Purchase | 2020-04-03 | 13G | Pluristem Therapeutics Inc. PSTI | CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | 1,092,057 6.100% | 1,092,057 (New Position) | Filing |